文献速递瓣膜病与结构性心脏病

经导管主动脉瓣置换术后亚临床瓣叶血栓与抗凝治疗综述

Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement: A Review.
PubMed 文献 · JAMA Cardiol · 2022-01-01

亚临床瓣叶血栓影响约15%的经导管主动脉瓣置换(TAVR)术后患者,其病理生理与临床意义尚不明确。三项近期随机试验证实口服抗凝(OAC)可预防亚临床瓣叶血栓,但总体上未带来临床获益,部分患者可能因出血风险而受害。识别OAC获益大于风险的患者是优化TAVR长期预后的关键。

要点

  • 亚临床瓣叶血栓约影响15%的TAVR术后患者
  • OAC可预防亚临床瓣叶血栓但总体无临床获益
  • 部分患者使用OAC可能因出血风险而受害

核心结论

  • OAC可有效预防TAVR术后亚临床瓣叶血栓,但总体上未带来临床获益,部分患者可能因出血风险受害。
  • 需要识别OAC获益大于风险的患者以优化TAVR长期预后。

研究设计与样本

  • 综述,汇总三项近期评估TAVR术后OAC作用的随机试验及既往观察性数据。

主要发现

  • 亚临床瓣叶血栓影响约15%的TAVR术后患者。
  • 三项近期随机试验证实OAC可预防亚临床瓣叶血栓,与既往观察性数据一致。
  • 总体上OAC在研究期间未带来临床获益,部分患者可能因出血风险而受害。
  • 亚临床瓣叶血栓的病理生理和临床意义仍未完全阐明。

临床怎么用

  • 对TAVR术后患者需权衡OAC预防亚临床瓣叶血栓的获益与出血风险。
  • 需进一步明确无症状瓣叶血栓的机制、临床意义及患者特异性出血与结构性瓣膜退化风险。

局限性

  • 亚临床瓣叶血栓的病理生理和临床意义尚未完全阐明。
  • OAC的临床净获益及适用人群尚需进一步研究明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Subclinical leaflet thrombosis affects approximately 15% of patients after transcatheter aortic valve replacement (TAVR). The pathophysiology and clinical significance of leaflet thrombosis remain incompletely understood. Defining the optimal management strategy in patients who are asymptomatic, including the role for oral anticoagulation (OAC), is a key challenge for the field. OBSERVATIONS: Three recent randomized trials have evaluated the role of OAC in patients after TAVR. These studies have confirmed prior observational data suggesting that OAC is effective at prevention of subclinical leaflet thrombosis. Overall, however, OAC does not lead to a clinical benefit over the period studied, and in some patients may be harmful owing to bleeding risk. CONCLUSIONS AND RELEVANCE: Strategies for identification of patients in whom the benefit of OAC outweighs the risks are required for optimization of long-term outcome after TAVR. This requires clearer insights into the mechanisms of asymptomatic leaflet thrombosis, its clinical significance, and patient-specific risks of bleeding and structural valve degeneration.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Cahill TJ, Kirtane AJ, Leon M, et al. Subclinical Leaflet Thrombosis and Anticoagulation After Transcatheter Aortic Valve Replacement: A Review. JAMA Cardiol. 2022. PMID: 35731530. doi:10.1001/jamacardio.2022.1591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。